SAEC to Use Cerner's Data Platform for Drug Reaction Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Scientists working with the International Serious Adverse Events Consortium will use Cerner's research platform in their efforts to understand genetic risks for liver injury and hypersensitivity reactions.

The SAEC said Wednesday that under a new collaboration its researchers will use the Cerner DiscovereT web-based research platform to collect data for studies of both of these types of adverse drug reactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.